GlassScriptPhysician profile
Anil B Kumar
NPI 1073619615
$5,198.42
in general payments reported to CMS, 2019-2025
49 companies · $617 in 2025
The $617 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $774 · 2020: $814 · 2021: $733 · 2022: $750 · 2023: $780 · 2024: $731 · 2025: $617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,127.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $774.18 | 2019-2024 | Myrbetriq, Xtandi |
| Medtronic, INC. | $525.53 | 2021-2025 | Interstim, Altaviva |
| Sumitomo Pharma America, INC. | $455.93 | 2023-2025 | Orgovyx, Gemtesa |
| Medtronic USA, INC. | $346.97 | 2019-2020 | |
| 180 Medical, INC. | $241.49 | 2019-2024 | Gentlecath |
| Blue Earth Diagnostics | $237.12 | 2019-2021 | |
| Coloplast Corp | $192.91 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $183.68 | 2019-2023 | Xiaflex |
| Allergan, INC. | $166.46 | 2019-2021 | |
| Tolmar Pharmaceuticals, INC. | $161.05 | 2019-2022 | |
| Urogen Pharma, INC. | $135.10 | 2024-2025 | |
| Pfizer INC. | $133.71 | 2019-2025 | |
| Olympus America INC. | $133.26 | 2021-2025 | Itind System |
| Boston Scientific Corporation | $115.97 | 2021-2025 | Spaceoar Vue System - 10ml, Axonics |
| Axonics, INC. | $110.80 | 2020-2023 | Axonics, Bulkamid |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $91.94 | 2022 | |
| Merck Sharp & Dohme LLC | $78.19 | 2020-2025 | Keytruda |
| Procept Biorobotics Corporation | $76.04 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Corelink, LLC | $75.70 | 2019 | |
| Abbvie INC. | $71.90 | 2022-2024 | |
| Nevro Corp. | $63.96 | 2020 | |
| Myriad Genetic Laboratories, INC. | $59.50 | 2021-2022 | |
| Antares Pharma, INC. | $57.73 | 2023-2025 | Xyosted, Nocdurna, Tlando |
| Janssen Biotech, INC. | $53.07 | 2025 | Erleada |
| Urovant Sciences INC | $45.78 | 2021-2022 | |
| Neotract INC. | $44.12 | 2020 | |
| Dendreon Pharmaceuticals LLC | $41.24 | 2024 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $36.75 | 2019-2022 | |
| Halozyme INC | $35.22 | 2023 | |
| Isoray, INC | $34.82 | 2021 | |
| Verity Pharmaceuticals INC. | $34.59 | 2022-2023 | Trelstar |
| Caldera Medical, INC | $33.82 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $33.66 | 2020 | |
| Metuchen Pharmaceuticals | $33.63 | 2019-2020 | |
| Dentsply Ih Ab | $31.87 | 2021-2024 | Lofric |
| Cook Medical LLC | $24.36 | 2019-2021 | |
| Laborie Medical Technologies Corp. | $22.60 | 2024 | Endosheath Technology |
| Conmed Corporation | $22.26 | 2021 | |
| Bioprotect Medical, INC. | $22.24 | 2025 | Bioprotect Balloon Implant System |
| Immunitybio, INC. | $21.17 | 2025 | |
| Photocure INC | $20.00 | 2023 | Cysview |
| Teleflex LLC | $18.43 | 2025 | Barrigel |
| Agiliti Surgical, INC. | $18.37 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $14.86 | 2025 | Lynparza |
| Medtronic Vascular, INC. | $14.42 | 2019 | |
| Alnylam Pharmaceuticals INC. | $13.84 | 2023 | Oxlumo |
| Dentsply Ih INC. | $12.90 | 2021 | |
| Acerus Pharmaceuticals Corporation | $12.87 | 2021 | |
| Eisai INC. | $12.41 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anil Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.